NCT06072807View on ClinicalTrials.gov

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast CancerBrain Metastases
Interventions
DIAGNOSTIC_TEST

Brain Imaging with 18F-FES

Using 18F-FES radiotracer in PET/CT scan to evaluate brain metastases in ER positive breast cancer patients.

Trial Locations (1)

10021

RECRUITING

New York-Presbyterian/Weill Cornell Medical Center, New York

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT06072807 - Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer | Biotech Hunter | Biotech Hunter